Recent OPDP enforcement letters target PR materials

11/27/2012

In a break from past practice, the FDA’s Office of Prescription Drug Promotion (OPDP) appears to be more closely scrutinizing drug companies’ public relations materials, as evidenced by two enforcement letters issued by OPDP last month citing a pitch letter and press releases. “Whether it’s a warning shot or a coincidence, it’s time for PR shops to brush up on the rules,” said Coalition for Healthcare Communication Executive Director John Kamp. Read more.

View Full Article in:

http://www.cohealthcom.org/2012/11/27/opdp-untitled-letters-on-pr-materials-surp...

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX